Open Science for global challenges & restoring the ethos of science
The EUA illustrates how the COVID-19 pandemic revealed the power of sharing research outputs in addressing global crises.
Do breastfeeding mothers have COVID vaccine side effects?
Researchers found that breastfeeding mothers and their infants faced no significant COVID vaccine side effects from the Pfizer and Moderna vaccines.
Optimising infection control post-pandemic
Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.
Enhancing safety and learning in schools through smart CO2 monitors
Hassan Sherbaz, Solutions Architect at Connexin, explains how smart monitoring solutions can help schools make informed decisions about ventilation across their buildings to protect students.
People with HIV more likely to experience heart attacks
Research by the American Heart Association found that people with HIV are more likely to experience heart attacks - with "higher rates of sudden cardiac death".
Implementation of unmanned aerial vehicles for cloud seeding
Eric Frew, University of Colorado, Research and Engineering Center for Unmanned Vehicles, explores the use of unmanned aerial vehicles (UAV) for more effective cloud seeding.
Rice crop: A vital cog in ensuring food security
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, argues that the rice crop is a vital cog in ensuring food security
Study reveals one in five older patients marked “do not resuscitate”
A study, published in BMJ Supportive & Palliative Care, found that one in five older, sick patients are recorded as "do not resuscitate" on admission.
Chemical industry: Towards the bioeconomy
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, argues that the chemical industry is one of the linchpins in Europe’s transition to a bioeconomy
Scientists begin work on COVID vaccines which can survive heat
Scientists at the University of California San Diego are developing COVID vaccines that can survive heat - using ideas from plants and bacteria.
Online safety – the ICO’s Children’s Code
Julian Hayes, Partner at BCL Solicitors LLP, examines the new Children's Code in relation to online harms which came into force on September 2nd.
SMEs missing out on billions by not investing their surplus cash
With banks paying just 0.05% on business savings, SMEs have the opportunity to earn much higher returns by investing their surplus cash in the stock market, says Andrey Dobrynin, Managing Director at InvestEngine.
Using performance analysis to help older people stay healthier for longer
Paul Berney, CMO at connected care platform Anthropos, explores how performance analysis, used to keep athletes healthy, can also be used to help older people stay healthier for longer.
Low code helps close the skills gap in the UK
Dan Blake, Managing Director EMEA, Claris, explores how the UK can close its growing skills gap with low code.
Smart tech help councils address tax arrears in a sustainable way
Paul Rudd, Director of Service Design at Civica, discusses the three-step approach local authorities should consider when dealing with COVID’s impact on council tax arrears.
Should the UK move to a care model similar to Europe?
Nicholas Kelly, Axela Innovations, discusses whether the UK should evolve the NHS to a care model similar to the Netherlands and Germany.
Evaluation of older adults with severe dementia
Professor Timothy Kwok of Jockey Club Centre for positive ageing, the Chinese University of Hong Kong, explores how to reliably evaluate older adults with severe dementia.
Japan: A case study of national “readiness” for regenerative medicine
This article focuses on Japan, as a country with a strong and distinctive strategy for delivering RM, and outlines efforts to build regenerative readiness.
Embarking on a disruptive way to treat Multiple Sclerosis and other serious immune diseases
Isabelle Ote and Valérie Barette, Project Leaders at Belgian immunotherapy expert Imcyse, discuss its next phase of growth, and how to apply ImotopeTM technology to the treatment of MS.
COVID-19: Antibody levels for the double-jabbed are waning
Dr Quinton Fivelman, PhD, Chief Scientific Officer at London Medical Laboratory, reveals that antibody levels for the double-jabbed are now waning. He asks was the UK Government unwise to relax most COVID precautions in July?.